Biochemical pathways are linked sequences of chemical reactions inside cells that convert starting materials into final products, with each step handled by a specific enzyme. They serve three broad purposes: extracting energy from nutrients, building the molecules cells need, and relaying information that tells a cell when to grow, divide, or die. What makes a pathway more than a random collection of reactions is its organization: each step feeds into the next, intermediates are shared or recycled, and the whole chain is tightly regulated so the cell produces just what it needs without wasting resources. Understanding these pathways is relevant well beyond biology class, since disruptions in them underlie conditions from cancer to rare inherited metabolic diseases, and deliberately manipulating them is now central to drug design and industrial biotechnology.
Breaking Things Down for Energy
Catabolic pathways disassemble larger molecules into smaller ones, releasing energy the cell can use. The classic example is glycolysis, a ten-step sequence that splits a six-carbon glucose molecule into two three-carbon molecules of pyruvate, producing a small amount of the cell’s energy currency, ATP, without requiring oxygen. Glycolysis is found in virtually every domain of life and is considered one of the most ancient metabolic routes. In organisms that breathe oxygen, glycolysis is just the opening act: pyruvate enters the mitochondria and feeds into the citric acid cycle (also called the TCA cycle or Krebs cycle), where it is broken down further while generating electron carriers that ultimately power a much larger burst of ATP through a process called oxidative phosphorylation.1Journal of Biological Chemistry. Glycolysis: A multifaceted metabolic pathway and signaling hub
The citric acid cycle does more than just burn fuel. It also hands off intermediate molecules that serve as raw materials for building amino acids, fatty acids, and other compounds the cell needs.2BioPublisher. The Central Role of the Citric Acid Cycle in Energy Metabolism: From Metabolic Intermediates to Regulatory Mechanisms This dual role, energy extraction and supply of building blocks, is a common theme. Pathways rarely exist in isolation; they overlap and share intermediates in a web that allows the cell to shift resources depending on conditions.
Building What the Cell Needs
Anabolic pathways run in the opposite metabolic direction: they consume energy to assemble small precursors into larger, more complex molecules. Synthesizing a new protein from amino acids, producing a lipid membrane from fatty acids, or constructing DNA from nucleotide building blocks all require anabolic pathways. These reactions are endergonic, meaning they won’t happen on their own. Cells drive them forward by coupling each step to an energy-releasing reaction, most often the breaking of a phosphate bond in ATP.
The balance between catabolic and anabolic pathways is not fixed. Cells constantly adjust the ratio depending on nutrient availability, energy demand, and growth signals. A key molecular switch in this balancing act is the enzyme AMPK, which acts as an energy sensor. When cellular energy reserves drop, AMPK activates catabolic pathways that generate ATP while simultaneously shutting down energy-consuming anabolic processes.3International Journal of Obesity. AMPK: a key regulator of energy balance in the single cell and the whole organism The interplay is not always perfectly proportional, though. Early assumptions that biomass production (anabolism) would always match the amount of ATP generated from catabolism turned out to be oversimplified; cells spend significant energy on maintenance tasks unrelated to growth.4PubMed Central. Energetics of bacterial growth: balance of anabolic and catabolic reactions
Photosynthesis as a Pathway
Not all biochemical pathways start with food. In plants, algae, and some bacteria, the Calvin-Benson-Bassham (CBB) cycle captures inorganic carbon dioxide and converts it into sugar phosphates using energy harvested from sunlight. The first step of this cycle is catalyzed by what may be the most abundant enzyme on Earth, ribulose-1,5-bisphosphate carboxylase/oxygenase, better known as Rubisco. Rubisco grabs a COâ‚‚ molecule and attaches it to a five-carbon sugar, producing a three-carbon compound that the rest of the cycle then converts into usable sugars.5PubMed Central. Ribulose-1,5-bisphosphate regeneration in the Calvin-Benson-Bassham cycle: Focus on the last three enzymatic steps that allow the formation of Rubisco substrate
Rubisco is famously slow and imprecise. It sometimes grabs oxygen instead of COâ‚‚, wasting energy in a side reaction. Over evolutionary time, a suite of helper proteins have assembled around Rubisco into what researchers have called a “RubisCOsome,” a complex that improves the enzyme’s performance under varying conditions.6PubMed Central. A short history of RubisCO: the rise and fall (?) of Nature’s predominant CO2 fixing enzyme The fact that evolution has spent hundreds of millions of years patching this enzyme rather than replacing it hints at how deeply embedded some pathways become once a cell’s entire chemistry is built around them.
Signaling Pathways That Relay Information
Biochemical pathways are not exclusively about metabolism. A large and critically important class of pathways exists to transmit signals, converting an extracellular cue into a cellular response. These signaling cascades do not usually break down or build molecules for energy; instead, they relay information by chemically modifying a chain of proteins, each one activating the next.
One of the most studied signaling cascades is the MAPK pathway. It works through a three-tier chain of enzymes, each of which phosphorylates (attaches a phosphate group to) the next, amplifying the original signal along the way. MAPK cascades regulate cell growth, differentiation, programmed cell death, and responses to stress. At least three major branches of this family have been identified, with the Ras/Raf/MEK/ERK branch playing a particularly important role in cancer cell survival.7PubMed Central. ERK/MAPK signalling pathway and tumorigenesis 8Cell Research. MAPK signal pathways in the regulation of cell proliferation in mammalian cells
Another well-characterized signaling route involves G-protein coupled receptors (GPCRs), a huge family of cell-surface receptors that respond to hormones, neurotransmitters, and sensory signals like light and odor. When a signaling molecule binds a GPCR, the receptor activates a G protein inside the cell, which in turn triggers production of cyclic AMP (cAMP), a small molecule that fans out to affect numerous downstream targets.9PubMed Central. Studying GPCR/cAMP pharmacology from the perspective of cellular structure The textbook version of this story holds that cAMP is produced only at the cell’s outer membrane, but research on the parathyroid hormone receptor showed that signaling can continue even after the receptor has been pulled inside the cell, where it keeps generating cAMP from an internal compartment.10Nature Chemical Biology. Sustained cyclic AMP production by parathyroid hormone receptor endocytosis Findings like this continue to revise long-held assumptions about where and how signaling pathways operate.
A third class of signaling pathway worth knowing about is the JAK-STAT pathway, which was originally discovered through research on how cells respond to interferons. When a cytokine or interleukin binds its receptor on the cell surface, it activates JAK enzymes, which phosphorylate STAT proteins. Those STAT proteins then pair up, travel to the nucleus, and directly switch on target genes.11PubMed Central. The JAK-STAT pathway at 30: Much learned, much more to do 12PubMed. The Jak-STAT pathway: cytokine signalling from the receptor to the nucleus The speed and directness of this route, going from receptor to gene activation with very few intermediaries, makes it a favorite mechanism for the immune system, which often needs to mount rapid responses.
How Pathways Regulate Themselves
A pathway running at full speed regardless of conditions would be wasteful at best and toxic at worst. Cells have evolved elegant control mechanisms, with feedback inhibition being one of the most fundamental. In feedback inhibition, the end product of a pathway binds to an enzyme near the beginning of that same pathway and slows it down. If the cell has plenty of the end product, the pathway effectively shuts itself off; as the product gets used up, the brake lifts and production resumes. One of the earliest and best-studied examples is the enzyme aspartate transcarbamoylase in pyrimidine biosynthesis, where the final nucleotide products CTP and UTP loop back to inhibit the very first enzyme in their own production chain.13PubMed. From feedback inhibition to allostery: the enduring example of aspartate transcarbamoylase
In amino acid biosynthesis, this same principle operates across at least seven different pathways. When researchers disabled the feedback mechanism in E. coli by introducing mutations that prevented the end-product amino acid from binding the pathway’s first enzyme, the bacteria overproduced that amino acid, often to their own detriment.14PubMed Central. Allosteric Feedback Inhibition Enables Robust Amino Acid Biosynthesis in E. coli by Enforcing Enzyme Overabundance 15PubMed Central. Insight into de-regulation of amino acid feedback inhibition: a focus on structure analysis method The results confirmed that allosteric feedback inhibition is not a luxury feature; it is essential for keeping biosynthesis balanced.
Another layer of control comes from rate-limiting enzymes, which sit at branch points in the metabolic network and act as traffic directors. In the human liver, these rate-limiting enzymes cluster around most of the major branch points in metabolism and produce nearly half of the known in vivo enzyme inhibitors, giving them outsized influence over which direction metabolites flow.16PubMed Central. Human liver rate-limiting enzymes influence metabolic flux via branch points and inhibitors
Why Pathways Need Their Own Rooms
Eukaryotic cells (the type found in animals, plants, and fungi) solve a major logistical problem by confining different pathways to membrane-bound compartments. Mitochondria handle oxidative phosphorylation. The endoplasmic reticulum folds and modifies proteins. Lysosomes digest worn-out components. This compartmentalization accomplishes three things: it creates distinct chemical environments where each pathway’s enzymes work best, it shields the rest of the cell from reactive or toxic intermediates, and it gives the cell an extra layer of regulation, because transporting a molecule across a membrane can serve as a control point.17PubMed Central. Principles and functions of metabolic compartmentalization
Compartmentalization also speeds things up. By concentrating metabolic precursors within a small volume, the local concentration is much higher than if those same molecules were diluted across the entire cell, and higher concentrations mean faster reaction rates.18Molecular Metabolism. Organelle transporters and inter-organelle communication as drivers of metabolic regulation and cellular homeostasis It also enables a division of labor: building reactions and dismantling reactions can run simultaneously in different organelles without interfering with each other.
When Pathways Go Wrong
Some of the most consequential disruptions to biochemical pathways occur in cancer. Nearly a century ago, Otto Warburg noticed that cancer cells consume far more glucose than normal cells and convert most of it into lactate, even when plenty of oxygen is available. This so-called Warburg effect initially seemed like a defect in mitochondria, but researchers have since shown that mitochondria in most cancers function normally.19PubMed Central. The Warburg Effect: How Does it Benefit Cancer Cells? 20PubMed. The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression Instead, cancer cells actively reprogram their metabolism to favor glycolysis because the intermediates generated along the way feed into biosynthetic pathways that supply the raw materials for rapid growth and proliferation.21PubMed Central. Metabolic reprogramming in cancer cells: glycolysis, glutaminolysis, and Bcl-2 proteins as novel therapeutic targets for cancer
On the inherited side, inborn errors of metabolism are rare genetic conditions in which a single enzyme in a biochemical pathway is absent or defective. Because each step depends on the one before it, a missing enzyme can cause a precursor to pile up to toxic levels or starve downstream reactions of a necessary product. These disorders can affect the processing of proteins, fats, or carbohydrates and can present with symptoms across many organ systems.22PubMed Central. Common metabolic disorder (inborn errors of metabolism) concerns in primary care practice Conditions like phenylketonuria (an inability to process the amino acid phenylalanine) and galactosemia (an inability to process the sugar galactose) are classic examples, and many are now caught through routine newborn screening.
Ancient Origins and Prebiotic Chemistry
How did these complex enzyme chains evolve in the first place? One clue comes from the observation that several reactions central to glycolysis and the pentose phosphate pathway can occur without enzymes at all, as long as certain metal ions and pH conditions are present. When researchers recreated a chemical environment resembling ancient ocean sediments, rich in ferrous iron and slightly acidic, they found that sugar phosphates underwent transformations mirroring the topology of modern metabolic networks.23PubMed Central. Conditional iron and pH-dependent activity of a non-enzymatic glycolysis and pentose phosphate pathway The implication is that enzymes did not invent these pathways from scratch; they sped up and refined chemical reactions that were already happening on early Earth.
Genomic evidence adds another piece. Glycolytic enzymes appear in organisms that cannot even eat glucose, such as hydrogen-dependent methanogens. These microbes use glycolysis-related enzymes not to break down external sugars but to manage internal carbon stores like glycogen. A recent analysis of enzyme distribution across prokaryotes suggests that the pathway originally ran in the gluconeogenic (sugar-building) direction, supporting amino acid and cofactor synthesis in the earliest cells, and only later was reversed for sugar breakdown when external glucose became available.24PubMed Central. The early evolution of the glycolytic pathway from autotrophic origins to glycogen and back
Pathways Shared Between Species
Biochemical pathways do not stop at a single cell’s boundary. In the gut, different species of bacteria trade metabolic by-products in a process called cross-feeding. One microbe’s waste product becomes another’s essential nutrient, and the resulting metabolic partnerships help establish communities that are stable, resistant to invasion, and important for host health.25PubMed Central. Cross-feeding in the gut microbiome: Ecology and mechanisms In one well-characterized example from fruit flies, the bacterium Acetobacter pomorum uses lactate produced by Lactobacillus plantarum to supply amino acids back to Lactobacillus, allowing it to grow on nutritionally imbalanced diets that neither species could handle alone.26Nature Communications. Metabolic cross-feeding in imbalanced diets allows gut microbes to improve reproduction and alter host behaviour
Extremophiles push pathway diversity even further. Organisms thriving in boiling hot springs, Antarctic ice, or highly acidic mine drainage have evolved specialized biochemical adaptations, sometimes including the ability to metabolize compounds that are toxic to most life.27PubMed Central. Metabolic adaptations of extremophiles and their applications in environmental biotechnology Cold-adapted bacteria in the genus Exiguobacterium, for instance, show enrichment in sulfur metabolism genes that help produce cryo-protective compounds like glycine betaine, linking environmental survival directly to specific metabolic pathway expansions.28The ISME Journal. Genomic basis of environmental adaptation in the widespread poly-extremophilic Exiguobacterium group
Engineering and Exploiting Pathways
Much of modern biotechnology amounts to rewiring biochemical pathways for human purposes. Metabolic engineering in yeast, for example, has been used to boost the production of fatty acids and fatty acid-derived biofuels by manipulating the pathway that converts acetyl-CoA into lipids.29PubMed Central. The Role of Metabolic Engineering Technologies for the Production of Fatty Acids in Yeast In amino acid production, engineering the rate-limiting enzyme argininosuccinate synthetase in a bacterial host increased L-arginine output to nearly 95 grams per liter while dramatically reducing by-product accumulation.30PubMed. Metabolic flux reprogramming and protein engineering drive efficient l-arginine biosynthesis
In drug discovery, understanding pathway flux, the rate at which metabolites move through each step, is becoming a major tool. Techniques like stable isotope-resolved metabolomics let researchers trace exactly where a labeled nutrient ends up inside a cell, revealing which pathways speed up or slow down in response to a drug candidate.31PubMed Central. Metabolomics-driven approaches for identifying therapeutic targets in drug discovery In cancer, where cells rewire their metabolism in tumor-specific ways, mapping these metabolic shifts helps identify enzyme targets that might sidestep the resistance problems that plague conventional treatments.32Drug Discovery Today: Therapeutic Strategies. Use of metabolic pathway flux information in targeted cancer drug design The challenge is precision: metabolic enzymes are shared between healthy cells and cancer cells, so designing drugs that hit the tumor’s metabolism without harming immune cells or normal tissues requires mapping vulnerabilities on both sides.33Nature Reviews Drug Discovery. Targeting cancer metabolism in the era of precision oncology
How Scientists Map These Pathways
The basic strategy for tracing a biochemical pathway is surprisingly old and still in use: feed a cell a molecule labeled with a rare but detectable atom, then follow where that atom ends up. In the 1930s, chemist Georg de Hevesy pioneered the concept of isotopic tracers, using radioactive phosphorus-32 to reveal the “dynamic character” of metabolism, the finding that the body is constantly building and dismantling its own components rather than existing as a static structure.34PubMed. The early history of (32) P as a radioactive tracer in biochemical research: A personal memoir Soon after, stable (non-radioactive) isotopes of carbon, nitrogen, oxygen, and hydrogen were introduced into organic molecules like amino acids, fatty acids, and sugars, allowing researchers to trace their metabolic fates in living systems.35PubMed Central. Historical and contemporary stable isotope tracer approaches to studying mammalian protein metabolism
Modern versions of this approach use mass spectrometry and nuclear magnetic resonance to track dozens of labeled metabolites simultaneously, painting a picture of pathway activity across an entire cell. Paired with genomics and proteomics, these tools allow researchers to build computational models of metabolism that predict how a cell will respond when a single enzyme is knocked out or a particular drug is applied. The pathways that once had to be inferred one reaction at a time can now be interrogated as complete networks, a shift that has made the field move faster but has also revealed just how interconnected and context-dependent these networks really are.